Gilmour Morrison

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects

Lesley Taylor, Barry E. Gidal, Graham Blakey et al. · CNS Drugs · 2018 · 464 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome

Orrin Devinsky, Anup D. Patel, Elizabeth A. Thiele et al. · Neurology · 2018 · 451 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

A Phase 1, Open‐Label, Pharmacokinetic Trial to Investigate Possible Drug‐Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects

Gilmour Morrison, Julie C. Crockett, Graham Blakey et al. · Clinical Pharmacology in Drug Development · 2019 · 195 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment

Lesley Taylor, Julie C. Crockett, Bola Tayo et al. · The Journal of Clinical Pharmacology · 2019 · 101 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects

Julie C. Crockett, David Critchley, Bola Tayo et al. · Epilepsia · 2020 · 74 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17